CCRM
Aditi Saini is a professional in the compliance and quality assurance sectors, currently serving as a Compliance Associate II at CCRM since February 2022, after progressing from a Compliance Associate I role. Prior experience includes positions at Ya YA Foods Corp. as an Internal Auditor specializing in GMP and Biosecurity, as well as roles in quality assurance and quality control. Aditi's career also includes quality control laboratory technician experience at Lantic Inc. and RPL (India) Pharmaceuticals Pvt. Ltd., and a tenure as a Knowledge Management Associate at ZS. Aditi holds an Advanced Diploma (High Honours) in Biotechnology-Advanced from Centennial College and a Bachelor of Pharmacy from the University of Delhi.
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.